Paper39728828
Acceptance and Completion Rates of 3-Month Isoniazid-Rifampicin (3HR) Tuberculosis Preventive Treatment (TPT) Among Contacts of Bacteriologically Confirmed TB Patients-Patients' and Healthcare Workers' Perspectives.
Ihesie A and 16 others. Trop Med Infect Dis, 2024. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Acceptance and Completion Rates of 3-Month Isoniazid-Rifampicin (3HR) Tuberculosis Preventive Treatment (TPT) Among Contacts of Bacteriologically Confirmed TB Patients-Patients' and Healthcare Workers' Perspectives. Papers, record 39728828. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39728828
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Acceptance and Completion Rates of 3-Month Isoniazid-Rifampicin (3HR) Tuberculosis Preventive Treatment (TPT) Among Contacts of Bacteriologically Confirmed TB Patients-Patients' and Healthcare Workers' Perspectives.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References20
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27393543 | A mixed-methods evaluation of adherence to preventive treatment among child tuberculosis contacts in Indonesia. | Int J Tuberc Lung Dis | 2016 | https://conductscience.org/library/papers/27393543 | PubMed |
| 2 | 36365009 | Preventive Treatment for Household Contacts of Drug-Susceptible Tuberculosis Patients. | Pathogens | 2022 | https://conductscience.org/library/papers/36365009 | PubMed |
| 3 | 31552416 | Determinants of Latent Tuberculosis Treatment Acceptance and Completion in Healthcare Personnel. | Clin Infect Dis | 2020 | https://conductscience.org/library/papers/31552416 | PubMed |
| 4 | 32664847 | Factors affecting uptake and completion of isoniazid preventive therapy among HIV-infected children at a national referral hospital, Kenya: a mixed quantitative and qualitative study. | BMC Infect Dis | 2020 | https://conductscience.org/library/papers/32664847 | PubMed |
| 5 | 14598961 | Passive versus active tuberculosis case finding and isoniazid preventive therapy among household contacts in a rural district of Malawi. | Int J Tuberc Lung Dis | 2003 | https://conductscience.org/library/papers/14598961 | PubMed |
| 6 | 28082666 | Isoniazid Preventive Therapy among Children Living with Tuberculosis Patients: Is It Working? A Mixed-Method Study from Bhopal, India. | J Trop Pediatr | 2017 | https://conductscience.org/library/papers/28082666 | PubMed |
| 7 | 30637106 | Grounded theory research: A design framework for novice researchers. | SAGE Open Med | 2019 | https://conductscience.org/library/papers/30637106 | PubMed |
| 8 | 28147705 | "It's about my life": facilitators of and barriers to isoniazid preventive therapy completion among people living with HIV in rural South Africa. | AIDS Care | 2017 | https://conductscience.org/library/papers/28147705 | PubMed |
| 9 | 24347732 | Management of children exposed to Mycobacterium tuberculosis: a public health evaluation in West Java, Indonesia. | Bull World Health Organ | 2013 | https://conductscience.org/library/papers/24347732 | PubMed |
| 10 | 34302733 | Vikela Ekhaya: A Novel, Community-based, Tuberculosis Contact Management Program in a High Burden Setting. | Clin Infect Dis | 2022 | https://conductscience.org/library/papers/34302733 | PubMed |
| 11 | 34193311 | Acceptance and completion of rifapentine-based TB preventive therapy (3HP) among people living with HIV (PLHIV) in Kampala, Uganda-patient and health worker perspectives. | Implement Sci Commun | 2021 | https://conductscience.org/library/papers/34193311 | PubMed |
| 12 | 36759036 | Optimising diagnosis and treatment of tuberculosis infection in community and primary care settings in two urban provinces of Viet Nam: a cohort study. | BMJ Open | 2023 | https://conductscience.org/library/papers/36759036 | PubMed |
| 13 | 28763500 | Child contact management in high tuberculosis burden countries: A mixed-methods systematic review. | PLoS One | 2017 | https://conductscience.org/library/papers/28763500 | PubMed |
| 14 | 36074775 | Effect of patient-delivered household contact tracing and prevention for tuberculosis: A household cluster-randomised trial in Malawi. | PLoS One | 2022 | https://conductscience.org/library/papers/36074775 | PubMed |
| 15 | 24932337 | Perceived barriers to the implementation of Isoniazid preventive therapy for people living with HIV in resource constrained settings: a qualitative study. | Pan Afr Med J | 2014 | https://conductscience.org/library/papers/24932337 | PubMed |
| 16 | 23485381 | Acceptance of treatment for latent tuberculosis infection: prospective cohort study in the United States and Canada. | Int J Tuberc Lung Dis | 2013 | https://conductscience.org/library/papers/23485381 | PubMed |
| 17 | 27196627 | Uptake of Isoniazid Preventive Therapy among Under-Five Children: TB Contact Investigation as an Entry Point. | PLoS One | 2016 | https://conductscience.org/library/papers/27196627 | PubMed |
| 18 | 39045000 | Tuberculosis preventive treatment in eight SEAR countries - Current practices, implementation challenges and operations research priorities. | Public Health Pract (Oxf) | 2024 | https://conductscience.org/library/papers/39045000 | PubMed |
| 19 | 34652990 | Factors associated with low tuberculosis preventive therapy prescription rates among health care workers in rural South Africa. | Glob Health Action | 2021 | https://conductscience.org/library/papers/34652990 | PubMed |
| 20 | 29577042 | Physicians' perspectives on communication and decision making in clinical encounters for treatment of latent tuberculosis infection. | ERJ Open Res | 2018 | https://conductscience.org/library/papers/29577042 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42646802 | Understanding Barriers to Uptake of TB Preventive Treatment Among People Living with HIV in Zimbabwe: A Qualitative Assessment of Healthcare Workers' Perspectives. | Trop Med Infect Dis | 2026 | https://conductscience.org/library/papers/42646802 | PubMed |
| 41798867 | Non-adherence and its predictors among pediatric household contacts on tuberculosis preventive therapy in the 3HP era: A multicenter observational study. | Ther Adv Infect Dis | 2026 | https://conductscience.org/library/papers/41798867 | PubMed |
| 41150373 | Evaluation of Tuberculosis Preventive Treatment Uptake Among People Living with HIV in PEPFAR-Supported Facilities in Zimbabwe. | Trop Med Infect Dis | 2025 | https://conductscience.org/library/papers/41150373 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39728828
GET https://conductscience.org/api/papers/v1/39728828/authors